Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-α and nitric oxide synthase
Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization
Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants
Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women
T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment
Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individuals
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen
High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
Tuberculosis risk varies with the duration of HIV infection
Mortality impact of AIDS in Addis Ababa, Ethiopia
Four-year behavioral outcomes of an intervention for parents living with HIV and their adolescent children
Shifts in condom use following microbicide introduction
Mother-to-child HIV transmission in resource poor settings
Do physicians provide counseling with HIV and STD testing at physician offices or hospital outpatient departments?
Sometimes help may not be enough
Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections
Prolonged retention of drug resistance mutations and rapid disease progression in the absence of therapy after primary HIV infection
Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples
The Mexican experience with the impact of banning the blood–plasma trade in preventing HIV transmission
Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapy
Inclusion body myositis